Viewing Study NCT05756556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-25 @ 8:01 AM
Study NCT ID: NCT05756556
Status: SUSPENDED
Last Update Posted: 2024-02-01
First Post: 2022-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma
Sponsor: ImmVira Pharma Co. Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Malignant Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None intratumoral (IT) injection View
None Cobimetinib View
None advanced melanoma View
None RAS mutation-positive View
None BRAF V600E/V600K mutation-positive View
None stage IIIB to IV advanced malignant melanoma View